HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Alaunos Therapeutics
Lyell Immunopharma, Inc.
University of Oklahoma
Wake Forest University Health Sciences
Institute of Cancer Research, United Kingdom
CureOne
Mayo Clinic
University of Louisville
Rutgers, The State University of New Jersey